Influenza surveillance in Western Turkey in the era of quadrivalent vaccines: A 2003–2016 retrospective analysis

References

• World Health Organization (WHO). Influenza (seasonal). Fact sheet N°211. March 2014. Available at http://www.who.int/mediacentre/factsheets/fs211/en/ (Accessed 13 September 2016).
   Google Scholar
• Ruigrok RWH. Structure of influenza A, B and C viruses. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. London: Blackwell Science; 1998. 29–42.
   Google Scholar
• Hay AJ, Gregory V, Douglas AR, Lin YP. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci. 2001;356:1861–70. PMID:11779385
   PubMed Web of Science ®Google Scholar
• Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine. 2010; 28 Suppl 4:D45–53.
   Google Scholar
• Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012;8:81–8. PMID:22252006
   PubMed Web of Science ®Google Scholar
• Hak E, Nordin J, Wei F, Mullooly J, Poblete S, Strikas R, Nichol KL. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis. 2002;35:370–7. PMID:12145718
   PubMed Web of Science ®Google Scholar
• Mangtani P, Cumberland P, Hodgson CR, Roberts JA, Cutts FT, Hall AJ. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis. 2004;190:1–10. PMID:15195237
   PubMed Web of Science ®Google Scholar
• Blank PR, Szucs TD. Increasing influenza vaccination coverage in recommended population groups in Europe. Expert Rev Vaccines. 2009;8:425–33. PMID:19348558
   PubMed Web of Science ®Google Scholar
• Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine. 2010;28:2149–56. PMID:20003926
   PubMed Web of Science ®Google Scholar
• Camilloni B, Neri M, Lepri E, Basileo M, Sigismondi N, Puzelli S, Donatelli I, Iorio AM. An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. Vaccine. 2010;28:7536–41. PMID:20846530
   PubMed Web of Science ®Google Scholar
• Dos Santos G, Neumeier E, Bekkat-Berkani R. Influenza: Can we cope better with the unpredictable? Hum Vaccin Immunother. 2016;12:699–708. PMID:26360135
   PubMed Web of Science ®Google Scholar
• Bekkat-Berkani R, Ray R, Jain VK, Chandrasekaran V, Innis BL. Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines. Expert Rev Vaccines. 2016;15:201–14. PMID:26641539
   PubMed Web of Science ®Google Scholar
• Watson JM. Surveillance of influenza. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. London: Blackwell Science; 1998 p.
   Google Scholar
• Akcay Ciblak MA, Kanturvardar Tutenyurd M, Asar S, Tulunoglu M, Findikci N, Badur S. [Influenza surveillance in nine consecutive seasons, 2003–2012: results from National Influenza Reference Laboratory, Istanbul Faculty Of Medicine, Turkey]. Mikrobiyol Bul. 2012;46:575–93. PMID:23188572
   PubMed Web of Science ®Google Scholar
• Mese S, Asar S, Tulunoglu M, Uyanık A, Yenen OŞ, Ağaçfidan A, Badur S. [Evaluation of sentinel influenza surveillance of the last two seasons: 2013–2014 and 2014-2015]. Mikrobiyol Bul. 2016;50:418–27. PMID:27525397
   PubMed Web of Science ®Google Scholar
• Altas AB, Bayrakdar F, Korukluoglu G. [Influenza surveillance in five consecutive seasons during post pandemic period: Results from National Influenza Center, Turkey]. Mikrobiyol Bul. 2016;50:401–17. PMID:27525396
   PubMed Web of Science ®Google Scholar
• Caini S, Huang QS, Ciblak MA, Kusznierz G, Owen R, Wangchuk S, Henriques CM, Njouom R, Fasce RA, Yu H. Epidemiological and virological characteristics of influenza B: Results of the Global Influenza B Study. Influenza Other Respir Viruses. 2015; 9 Suppl 1:3–12.
   Google Scholar
• Barr IG, Jelley LL. The coming era of quadrivalent human influenza vaccines: Who will benefit? Drugs. 2012;72:2177–85. PMID:23110610
   PubMed Web of Science ®Google Scholar
• Demicheli V, Di Pietrantonj C, Jefferson TO, Rivetti A, Rivetti D. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2007:CD001269.
   Google Scholar
• Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010:CD001269.
   Google Scholar
• Demicheli V, Jefferson T, Al-Ansary LA, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2014:CD001269.
   Google Scholar
• Kanegae Y, Sugita S, Endo A, Ishida M, Senya S, Osako K, Nerome K, Oya A. Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: Cocirculating lineages in the same epidemic season. J Virol. 1990;64:2860–5. PMID:2335820
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec. 2012;87:461–76. Available at http://www.who.int/influenza/vaccines/virus/recommendations/en/ (Accessed 28 December 2016). PMID:23210147
   PubMedGoogle Scholar
• Finkelman BS, Viboud C, Koelle K, Ferrari MJ, Bharti N, Grenfell BT. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS One. 2007;2:e1296. PMID:18074020
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). FluNet. Available at http://www.who.int/influenza/gisrs_laboratory/flunet/en/ (Accessed 13 September 2016).
   Google Scholar
• Radin JM, Hawksworth AW, Myers CA, Ricketts MN, Hansen EA, Brice GT. Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014Vaccine 2016;34:3907–12. PMID:27265447
   PubMed Web of Science ®Google Scholar
• Sosyal Güvenlik Kurumu (SGK). DUYURU. Available at http://www.sgk.gov.tr/duyurular/genel_saglik_sigortasi/25.05.2011_Grip%20Asilari.pdf (Accessed 12 January 2017).
   Google Scholar
• Ciblak MA, Platformu G. Influenza vaccination in Turkey: Prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Vaccine. 2013;31:518–23. PMID:23174194
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). CDC protocol of realtime RTPCR for influenza A(H1N1). Available at http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf (Accessed 13 September 2016).
   Google Scholar
• Biere B, Bauer B, Schweiger B. Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR. J Clin Microbiol. 2010;48:1425–7. PMID:20107085
   PubMed Web of Science ®Google Scholar
• Centers for Diseases Control and Prevention. Guidance for clinicians on the use of RT-PCR and other molecular assays for diagnosis of influenza virus infection. Available from: http//www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm.
   Google Scholar
• Mahony JB. Nucleic acid amplification-based diagnosis of respiratory virus infection. Expert Rev Anti Infect Ther. 2010;8:1273–92 PMID:21073292
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Terms of Reference for National Influenza Centres. Available at http://www.who.int/influenza/gisrs_laboratory/national_influenza_centres/terms_of_reference_for_national_influenza_centres.pdf?ua=1 (Accessed 17 October 2016).
   Google Scholar
• World Health Organization (WHO). Selection of clinical specimens for virus isolation and of viruses for shipment from National Influenza Centres to WHO Collaborating Centres. Available at http://www.who.int/influenza/gisrs_laboratory/national_influenza_centres/20101206_specimens_selected_for_virus_isolation_and_shipment.pdf (Accessed 17 October 2016).
   Google Scholar